Vistara™ Single-Gene NIPT
Use
Vistara™ is a prenatal single-gene screening test designed to identify serious genetic conditions that could significantly impact quality of life. The test screens for 25 autosomal dominant and X-linked conditions by analyzing 30 genes. Detection of such conditions can guide early interventions, informing pregnancy and delivery management decisions. Due to its comprehensive scope, Vistara™ offers clinically actionable insights not typically accessible through standard non-invasive prenatal testing alone.
Special Instructions
Not provided.
Limitations
Vistara™ is a screening tool and not a diagnostic test. It means that while the test can indicate an increased risk of certain conditions, it cannot provide a definitive diagnosis. A screen-positive result suggests a possibility of the condition, but further diagnostic testing is needed to confirm whether the fetus is affected. Prenatal diagnostic testing during pregnancy, such as amniocentesis or chorionic villus sampling (CVS), is recommended for confirmation.
Methodology
NGS (Targeted)
Biomarkers
SON
Gene
Result Turnaround Time
2-3 weeks
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
With only one blood draw from the mother required, the test can be ordered seamlessly.
Other tests from different labs that may be relevant